Provided by Tiger Trade Technology Pte. Ltd.

LIFECORE BIOMEDICAL INC

6.52
-0.0200-0.31%
Post-market: 6.520.00000.00%19:30 EDT
Volume:840.59K
Turnover:5.48M
Market Cap:246.80M
PE:-7.04
High:6.57
Open:6.54
Low:6.51
Close:6.54
52wk High:8.98
52wk Low:3.63
Shares:37.85M
Float Shares:19.33M
Volume Ratio:0.61
T/O Rate:4.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9257
EPS(LYR):-0.5400
ROE:-76.41%
ROA:-3.04%
PB:-17.38
PE(LYR):-12.07

Loading ...

Lifecore Biomedical (LFCR) was downgraded to a Hold Rating at William Blair

TIPRANKS
·
Yesterday

Lifecore Extends Manufacturing Contract With Alcon Research

MT Newswires Live
·
Sep 30

Lifecore Biomedical Unit Lifecore Biomedical LLC Extends Alcon Manufacturing Pact Term to 2034

Reuters
·
Sep 30

Lifecore Biomedical - Agrees to Non-Compete on Certain Products with Alcon from November 1, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 30

Lifecore Biomedical \De\ - Alcon Minimum Purchase Obligations Established Through 2034 - SEC Filing

THOMSON REUTERS
·
Sep 30

Lifecore Biomedical - Unit Enters Amendment No. 3 to Contract Manufacturing Agreement with Alcon Effective Nov 1, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 30

Lifecore Biomedical - Contract Manufacturing Agreement Term Extended to December 31, 2034 - SEC Filing

THOMSON REUTERS
·
Sep 30

Barrington Downgrades Lifecore Biomedical to Market Perform From Outperform, Removes $6.25 Price Target

MT Newswires Live
·
Sep 29

Lifecore Biomedical, Inc. : Barrington Research Cuts to Market Perform from Outperform

THOMSON REUTERS
·
Sep 29

Lifecore Biomedical Cut to Market Perform from Outperform by William Blair

Dow Jones
·
Sep 29

Lifecore downgraded to Hold from Buy at Craig-Hallum

TIPRANKS
·
Sep 29

Lifecore downgraded to Market Perform from Outperform at William Blair

TIPRANKS
·
Sep 29

William Blair downgrades Lifecore Biomedical (LFCR) to a Hold

TIPRANKS
·
Sep 29

Lifecore Biomedical trading resumes

TIPRANKS
·
Sep 28

Lifecore Biomedical Agrees to be Acquired by Webster Equity Partners for USD 6.28 a Share Plus CVR

Reuters
·
Sep 28

Lifecore Biomedical - Stockholders May Receive up to $9.67 Per Common Equivalent at Full Milestone Payments

THOMSON REUTERS
·
Sep 28

Lifecore Biomedical, - to be Bought by Webster Equity Partners in Deal Valued up to $663.70 Mln

THOMSON REUTERS
·
Sep 28

NASDAQ Trade Halt Halt News Pending at 08:40 Am

Reuters
·
Sep 28

Lifecore Biomedical to Attend CPHI Global Conference

Reuters
·
Sep 04

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)

TIPRANKS
·
Sep 03